4//SEC Filing
Thorpe Mark 4
Accession 0001209191-23-046240
CIK 0001719395other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:09 PM ET
Size
22.7 KB
Accession
0001209191-23-046240
Insider Transaction Report
Form 4
Eargo, Inc.EAR
Thorpe Mark
Chief Accounting Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-08-15−20,000→ 0 totalExercise: $11.58Exp: 2033-01-31→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-15−20,000→ 0 totalExercise: $11.58Exp: 2033-01-31→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-15+35,000→ 35,000 totalExercise: $3.31Exp: 2033-08-14→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-15−101→ 0 totalExercise: $1026.60Exp: 2031-03-08→ Common Stock (101 underlying) - Award
Stock Option (Right to Buy)
2023-08-15+20,000→ 20,000 totalExercise: $3.31Exp: 2033-01-31→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-15+20,000→ 20,000 totalExercise: $3.31Exp: 2033-01-31→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-15+101→ 101 totalExercise: $3.31Exp: 2031-03-08→ Common Stock (101 underlying) - Sale
Common Stock
2023-08-17$3.23/sh−3$10→ 1,064 total
Footnotes (8)
- [F1]Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person.
- [F2]The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F3]The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price.
- [F4]The Stock Option vests and becomes exercisable as to 20% of the shares subject to the stock option on February 15, 2024 (the "Vesting Start Date"), with the remainder vesting in 16 equal quarterly installments thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F5]The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, provided, that, any unvested portion of the Stock Option shall vest and become exercisable upon attainment of a 360-day VWAP (volume weighted average price) of $20.00 for the Issuer's Common Stock, in either case, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F6]The Stock Option vests and becomes exercisable in full upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock on or prior to February 15, 2028, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through such date.
- [F7]The Stock Option shall vest and become exercisable in 16 quarterly installments commencing on February 15, 2021 until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the vesting start date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F8]On January 17, 2023, the Issuer effected a 1-for-20 reverse stock split of its Common Stock (the "Reverse Stock Split"). These securities reflect the Reverse Stock Split.
Documents
Issuer
Eargo, Inc.
CIK 0001719395
Entity typeother
Related Parties
1- filerCIK 0001904919
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:09 PM ET
- Size
- 22.7 KB